ProFibrix BV

Entity type image
Type: Company
Name: ProFibrix BV
First reported Jun 12 2013 - Updated Jun 12 2013 - 1 reports
Goldman Sachs Group Inc
Goldman Sachs Group Inc

The Medicines Company's CEO Presents at Goldman Sachs 34th Annual Global Healthcare Conference (Transcript)

The Medicines Company (MDCO) Goldman Sachs 34th Annual Global Healthcare Conference Call June 11, 2013 4:20 PM ETNavdeep Singh – Goldman SachsAll right, good afternoon everyone and thank you for attending the Annual Global Goldman Sachs Healthcare Conference. ... [Published Seeking Alpha - Jun 12 2013]
First reported Jun 11 2013 - Updated Jun 11 2013 - 1 reports

The Medicines Company to acquire ProFibrix BV

The Medicines Company has agreed to acquire ProFibrix BV from Gilde Healthcare Partners, INKEF Capital, Vesalius Biocapital Partners Sarl and Index Ventures for a total consideration of $100 million.Value: $100 millionParties involvedLegal advisersThe ... [Published International Law Office - Jun 11 2013]
First reported Jun 11 2013 - Updated Jun 11 2013 - 1 reports

[TMC] receives option to acquire surgical sealants maker [ProFibrix] for $10mm up front

Home » Blogs » Related Biotechnology, Pharmaceutical and Healthcare News[The Medicines Co.] (TMC; critical care products) has paid $10mm up front for an option to acquire privately held [ProFibrix BV] (topical surgical sealants used in hemostasis and ... [Published BioPortfolio - Jun 11 2013]
First reported Jun 06 2013 - Updated Jun 06 2013 - 1 reports

Vectura set for £2m payment

Vectura Group in Chippenham could be in line for a 2m payment as part of US drug maker The Medicines Company's planned acquisition of Netherlands-based ProFibrix.Vectura has licensed payments to ProFibrix for the Fibrocaps drug, which is being developed ... [Published Insider Media Limited - Jun 06 2013]
First reported Jun 05 2013 - Updated Jun 05 2013 - 3 reports
Motley Fool
Motley Fool

The Medicines Company May Buy Company Behind Surgical Bleeding Inhibitor

Filed under: InvestingIf all goes well in phase 3 trials for ProFibrix's lead biologic, Fibrocaps -- a treatment to stop bleeding during surgery -- shareholders of the Netherlands-based drugmaker could receive a hefty payday from The Medicines Company ... [Published Daily Finance - Jun 05 2013]
First reported Jun 04 2013 - Updated Jun 05 2013 - 8 reports
Vectura Group plc
Vectura Group plc

Vectura: Potential Royalty and Milestone Payments on Fibrocaps

Vectura Group plc – Potential royalty and milestone payments on Fibrocaps™ 04 June 2013Chippenham, UK – 4th June 2013: Vectura Group plc ("Vectura" or the "Company"; LSE: VEC), announces that the Company could receive a £2m change of control payment as ... [Published Pharma Live - Jun 05 2013]
First reported Jun 04 2013 - Updated Jun 04 2013 - 1 reports
The Medicines Company
The Medicines Company

TMC Likes Its Options: Hospital Marketer Gains Rights To ProFibrix

The Medicines Company agreed to pay $10 million upfront to ProFibrix for an option to acquire the company outright after Phase III data on the lead biologic, Fibrocaps, read out later this year. ... [Published The Rose Sheet - Jun 04 2013]
First reported Jun 04 2013 - Updated Jun 04 2013 - 7 reports

Study to Decide Fate of Profibrix

Drug developer The Medicines Co. plans to buy ProFibrix BV in a deal that will hinge on late-stage study results for a topical powder that the company is developing to stop bleeding during or after surgery.Medicines Co. said it will make a $10 million ... [Published Drug Discovery and Development - Jun 04 2013]
First reported Jun 04 2013 - Updated Jun 04 2013 - 1 reports

Cytokinetics Announces Publications Relating to Fast Skeletal Troponin Activation in Nemaline Myopathy

The Medicines Company Signs Agreement to Acquire ProFibrix Jun 4, 2013Analyses of MPACT Trial Evaluating ABRAXANE® Combination Therapy for the Treatment of Advanced Pancreatic Cancer Presented at ASCO 2013 Jun 4, 2013Cellceutix Presents Poster at ASCO ... [Published AndhraNews.net - Jun 04 2013]
First reported Jun 04 2013 - Updated Jun 04 2013 - 1 reports

Medicines Co Signs Agreement To Acquire ProFibrix B.V

11:04am BSTMedicines Co and ProFibrix B.V. announced an agreement for The Medicines Company to purchase all of the outstanding capital stock of ProFibrix B.V. subject to The Medicines Company's satisfactory review of the pending Phase 3 clinical trial ... [Published Reuters UK - Jun 04 2013]
First reported Apr 04 2013 - Updated Apr 05 2013 - 1 reports

ProFibrix Completes Patient Enrolment in Pivotal Phase III with FibrocapsTM and Reports Positive Feedback Business Wire

LEIDEN, The Netherlands & SEATTLE--(BUSINESS WIRE)-- ProFibrix B.V., a leader in the development of innovative bioactive products to stop bleeding (hemostasis), today announced that the company has completed enrolment of its pivotal Phase III clinical ... [Published Yahoo! Finance - Apr 04 2013]

Quotes

More From BioPortfolio on "[TMC] receives option to acquire surgical sealants maker [ProFibrix] for $10mm up front"
[TMC] receives option to acquire surgical sealants maker [ProFibrix] for $10mm up front [Published BioPortfolio - Jun 11 2013]
Dr Chris Blackwell, chief executive of Vectura, said: "[This] announcement further demonstrates Vectura's commitment to monetise value from its extensive intellectual property portfolio."
Vectura set for £2m payment [Published Insider Media Limited - Jun 06 2013]
The Medicines CompanyMedicines Company CEO Clive Meanwell said:  "If approved by the regulatory authorities, we believe Fibrocaps will become a leading hemostatic product -- complementary to Recothrom Thrombin, topical (Recombinant). This would allow us to leverage our frontline activities in surgery centers at leading U S hospitals and potentially accelerate our entry into the European market."
The Medicines Company May Buy Company Behind Surgical Bleeding Inhibitor [Published Daily Finance - Jun 05 2013]
...Öhrström, MD, Chief Executive Officer of ProFibrix and former Senior Vice President of Development and Chief Medical Officer of ZymoGenetics said, "Having led the development of Recothrom, it is clear to me that the ProFibrix team, our technology platform and our lead product are a strategic fit with The Medicines Company's perioperative and hemostasis programs."
The Medicines Company To Acquire ProFibrix [Published Citybizlist - Jun 04 2013]

More Content

All (30) | News (24) | Reports (1) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (4)
sort by: Date | Relevance
The Medicines Company's CEO Presents at Goldman... [Published Seeking Alpha - Jun 12 2013]
The Medicines Company to acquire ProFibrix BV [Published International Law Office - Jun 11 2013]
[TMC] receives option to acquire surgical seala... [Published BioPortfolio - Jun 11 2013]
Vectura set for £2m payment [Published Insider Media Limited - Jun 06 2013]
The Medicines Company May Buy Company Behind Su... [Published Daily Finance - Jun 05 2013]
The Medicines Co. Inks Deal with ProFibrix Zacks [Published Yahoo! Finance - Jun 05 2013]
Vectura: Potential Royalty and Milestone Paymen... [Published Pharma Live - Jun 05 2013]
Acquisition triggers £2m Vectura bonus [Published Business Weekly UK - Jun 05 2013]
Medicines Co. to Acquire ProFibrix [Published Dow Jones Financial Information Services - Jun 05 2013]
TMC Likes Its Options: Hospital Marketer Gains ... [Published The Rose Sheet - Jun 04 2013]
Vectura Potential Royalty and Milestone Payment... [Published Big News Network - Jun 04 2013]
Study to Decide Fate of Profibrix [Published Drug Discovery and Development - Jun 04 2013]
Vectura Group plc Potential Royalty and Milesto... [Published BioSpace - Jun 04 2013]
Vectura Group plc (VEC.L) Potential Royalty and... [Published BioSpace - Jun 04 2013]
RBC Believes Medicines Co. Option to Buy ProFib... [Published Benzinga.com - Jun 04 2013]
Parsippany-based Medicines Co. will buy Dutch d... [Published Star Ledger - Jun 04 2013]
The Medicines Company Agrees $10M Option Deal t... [Published Pharma-Mag - Jun 04 2013]
Cytokinetics Announces Publications Relating to... [Published AndhraNews.net - Jun 04 2013]
Medicines Co Signs Agreement To Acquire ProFibr... [Published Reuters UK - Jun 04 2013]
The Medicines Company To Acquire ProFibrix [Published Citybizlist - Jun 04 2013]
VECTURA GROUP PLC : Potential royalty and mile... [Published 4 Traders - Jun 04 2013]
Medicines Co. (MDCO) to Acquire ProFibrix B.V. ... [Published Street Insider - Jun 04 2013]
Vectura in line for £2m payment [Published Stock Market Wire - Jun 04 2013]
Vectura Group plc : Potential Fibrocaps royalty... [Published Investegate - Jun 04 2013]
The Medicines Company to Acquire ProFibrix with... [Published Benzinga.com - Jun 04 2013]
The Medicines Company Signs Agreement to Acquir... [Published Marketwire - Breaking News Releases - Jun 04 2013]
ProFibrix Completes Patient Enrolment in Pivota... [Published Yahoo! Finance - Apr 04 2013]
ProFibrix Completes Patient Enrolment in Pivota... [Published Business Wire Health News - Apr 04 2013]
ProFibrix Phase III Trial with FibrocapsTM (FIN... [Published EON Health & Medicine - Feb 13 2013]
ProFibrix Phase III Trial with FibrocapsTM (FIN... [Published Business Wire Health News - Feb 13 2013]
1
In Focus
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
The Medicines Company Agrees $10M Option Deal t... [Published Pharma-Mag - Jun 04 2013]
Prospective buyout will depend on data from Phase III trial with topical fibrinogen and thrombin product The Medicines Company has agreed to shell out $10 million to secure an option to acquire Netherlands-based ProFibrix, which is developing Fibrocaps, ...
1

Press Releases

sort by: Date | Relevance
The Medicines Company Signs Agreement to Acquir... [Published Marketwire - Breaking News Releases - Jun 04 2013]
ProFibrix Completes Patient Enrolment in Pivota... [Published Business Wire Health News - Apr 04 2013]
ProFibrix Phase III Trial with FibrocapsTM (FIN... [Published EON Health & Medicine - Feb 13 2013]
ProFibrix Phase III Trial with FibrocapsTM (FIN... [Published Business Wire Health News - Feb 13 2013]
1
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.